Clinical trial
Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in…
NCT00231075 · ARCAGY/ GINECO GROUP, Other · Completed
Key facts
| NCT number | NCT00231075 |
|---|---|
| Title | Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV |
| Official title | National, Phase II Study Designed to Evaluate the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III and IV. FAG-2 |
| Lead sponsor | ARCAGY/ GINECO GROUP, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Paraplatin, Paclitaxel |
| Enrollment | 75 |
| Start date | Jan 1, 2001 |
| Completion | May 1, 2007 |
| First posted | Oct 4, 2005 |
| Last update posted | Nov 3, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: